Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure

Axel Brandes; Harry J. G. M. Crijns; Michiel Rienstra; Paulus Kirchhof; Erik L. Grove; Kenneth Bruun Pedersen; Isabelle C. Van Gelder

doi:10.1093/europace/euaa057

Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure

Axel Brandes^*, Harry J. G. M. Crijns, Michiel Rienstra, Paulus Kirchhof, Erik L. Grove, Kenneth Bruun Pedersen, Isabelle C. Van Gelder

^*Corresponding author for this work

Research output: Contribution to journal › (Systematic) Review article › peer-review

Abstract

Cardioversion is widely used in patients with atrial fibrillation (AF) and atrial flutter when a rhythm control strategy is pursued. We sought to summarize the current evidence on this important area of clinical management of patients with AF including electrical and pharmacological cardioversion, pert-procedural anticoagulation and thromboembolic complications, success rate, and risk factors for recurrence to give practical guidance.

Original language	English
Pages (from-to)	1149-1161
Number of pages	13
Journal	EP Europace
Volume	22
Issue number	8
DOIs	https://doi.org/10.1093/europace/euaa057
Publication status	Published - Aug 2020

Keywords

Atrial fibrillation
Atrial flutter
Electrical cardioversion
Pharmacological cardioversion
Anticoagulation
Thromboembolism
VITAMIN-K ANTAGONIST
MULTIDETECTOR COMPUTED-TOMOGRAPHY
CURRENT ELECTRICAL CARDIOVERSION
ANTIARRHYTHMIC-DRUG TREATMENT
DIRECT ORAL ANTICOAGULANTS
APPENDAGE FILLING DEFECTS
TISSUE DOPPLER DYNAMICS
MAINTAIN SINUS RHYTHM
TRANSESOPHAGEAL ECHOCARDIOGRAPHY
EXTERNAL CARDIOVERSION

Access to Document

10.1093/europace/euaa057Licence: CC BY-NC

Cite this

@article{2322aa15cee24cbfbb9aeb68e0f85c73,

title = "Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure",

abstract = "Cardioversion is widely used in patients with atrial fibrillation (AF) and atrial flutter when a rhythm control strategy is pursued. We sought to summarize the current evidence on this important area of clinical management of patients with AF including electrical and pharmacological cardioversion, pert-procedural anticoagulation and thromboembolic complications, success rate, and risk factors for recurrence to give practical guidance.",

keywords = "Atrial fibrillation, Atrial flutter, Electrical cardioversion, Pharmacological cardioversion, Anticoagulation, Thromboembolism, VITAMIN-K ANTAGONIST, MULTIDETECTOR COMPUTED-TOMOGRAPHY, CURRENT ELECTRICAL CARDIOVERSION, ANTIARRHYTHMIC-DRUG TREATMENT, DIRECT ORAL ANTICOAGULANTS, APPENDAGE FILLING DEFECTS, TISSUE DOPPLER DYNAMICS, MAINTAIN SINUS RHYTHM, TRANSESOPHAGEAL ECHOCARDIOGRAPHY, EXTERNAL CARDIOVERSION",

author = "Axel Brandes and Crijns, {Harry J. G. M.} and Michiel Rienstra and Paulus Kirchhof and Grove, {Erik L.} and Pedersen, {Kenneth Bruun} and {Van Gelder}, {Isabelle C.}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.",

year = "2020",

month = aug,

doi = "10.1093/europace/euaa057",

language = "English",

volume = "22",

pages = "1149--1161",

journal = "EP Europace",

issn = "1099-5129",

publisher = "Oxford University Press",

number = "8",

}

TY - JOUR

T1 - Cardioversion of atrial fibrillation and atrial flutter revisited

T2 - current evidence and practical guidance for a common procedure

AU - Brandes, Axel

AU - Crijns, Harry J. G. M.

AU - Rienstra, Michiel

AU - Kirchhof, Paulus

AU - Grove, Erik L.

AU - Pedersen, Kenneth Bruun

AU - Van Gelder, Isabelle C.

N1 - Publisher Copyright: © The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.

PY - 2020/8

Y1 - 2020/8

N2 - Cardioversion is widely used in patients with atrial fibrillation (AF) and atrial flutter when a rhythm control strategy is pursued. We sought to summarize the current evidence on this important area of clinical management of patients with AF including electrical and pharmacological cardioversion, pert-procedural anticoagulation and thromboembolic complications, success rate, and risk factors for recurrence to give practical guidance.

AB - Cardioversion is widely used in patients with atrial fibrillation (AF) and atrial flutter when a rhythm control strategy is pursued. We sought to summarize the current evidence on this important area of clinical management of patients with AF including electrical and pharmacological cardioversion, pert-procedural anticoagulation and thromboembolic complications, success rate, and risk factors for recurrence to give practical guidance.

KW - Atrial fibrillation

KW - Atrial flutter

KW - Electrical cardioversion

KW - Pharmacological cardioversion

KW - Anticoagulation

KW - Thromboembolism

KW - VITAMIN-K ANTAGONIST

KW - MULTIDETECTOR COMPUTED-TOMOGRAPHY

KW - CURRENT ELECTRICAL CARDIOVERSION

KW - ANTIARRHYTHMIC-DRUG TREATMENT

KW - DIRECT ORAL ANTICOAGULANTS

KW - APPENDAGE FILLING DEFECTS

KW - TISSUE DOPPLER DYNAMICS

KW - MAINTAIN SINUS RHYTHM

KW - TRANSESOPHAGEAL ECHOCARDIOGRAPHY

KW - EXTERNAL CARDIOVERSION

U2 - 10.1093/europace/euaa057

DO - 10.1093/europace/euaa057

M3 - (Systematic) Review article

C2 - 32337542

SN - 1099-5129

VL - 22

SP - 1149

EP - 1161

JO - EP Europace

JF - EP Europace

IS - 8

ER -

Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure

Abstract

Keywords

Access to Document

Fingerprint

Cite this